4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-027076
Options or other derivatives
- Director acquired 1,494 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Saad Mark E Director | 2025-02-21 | Grant or award · Stock Option (Right to Buy) | +1,494 | 1,494 | D | ||
Loading xslF345X05/ownership.xml…